Apretude: Uses, Dosage, Side Effects, Warnings - Drugs.com
2025年1月24日 · Apretude (cabotegravir extended-release injection) is a long-acting injection for HIV pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection. …
Long-acting PrEP | APRETUDE (cabotegravir)
APRETUDE is a prescription medicine used for HIV-1 PrEP to reduce the risk of getting HIV-1 infection in adults and adolescents who weigh at least 77 pounds (at least 35 kg). APRETUDE …
FDA Approves First Injectable Treatment for HIV Pre-Exposure ...
Today, the U.S. Food and Drug Administration approved Apretude (cabotegravir extended-release injectable suspension) for use in at-risk adults and adolescents weighing at least 35...
APRETUDE is an injectable PrEP administered every other month* • APRETUDE (cabotegravir 600 [3mL]) is an HIV-1 integrase strand transfer inhibitor (INSTI) in an extended-release …
Administration approved Apretude® (cabotegravir extended-release injectable suspension) for PrEP, making it the first LAI medication option available for the primary prevention of HIV. …
APRETUDE is an HIV-1 integrase strand transfer inhibitor (INSTI) indicated in at-risk adults and adolescents weighing at least 35 kg for PrEP to reduce the risk of sexually acquired HIV-1...
Apretude (cabotegravir) - Uses, Side Effects, and More - WebMD
2024年9月29日 · Apretude (cabotegravir injection) is commonly used to prevent HIV through sexual contact (pre-exposure prophylaxis, also called PrEP). Learn more about Apretude for …
Cabotegravir: Uses, Dosage, Side Effects, Warnings - Drugs.com
2025年1月24日 · Cabotegravir extended-release injection (brand name Apretude) is used to reduce the risk of getting HIV-1 infection from sex in adults and adolescents who weigh at …
- 某些结果已被删除